News

This edition of Infection Intel from Infection Control Today covers infection control and prevention company news out of IDWeek, being held in Boston, Massachusetts, from October 11 to 15, 2023.

FDA approved emergency use of Novavax COVID-19 vaccine (NVX-CoV2601) for ages 12 years and older. It also protects against current variants.

In the delicate world of neonatal care, every precaution is taken to protect premature infants in the Neonatal Intensive Care Unit (NICU). It's crucial to acknowledge the strides made in safeguarding these vulnerable infants, whose wellbeing hinges on the meticulous efforts of health care professionals and evolving best practices.

Heating, ventilation, and air conditioning (HVAC) systems are vital for maintaining air quality in health care facilities. They play a crucial role in reducing disease transmission by regulating air quality. Proper HVAC systems decrease risk through ventilation, filtration, and airflow control.

Cases of COVID-19, RSV, and influenza are expected to rise this fall and winter season; yet, the number of people who plan on getting the vaccines for each of the infections remains low, according to the NFID announcement today.

Deborah Birx, MD, highlights concerns about the lack of data-driven action in the fight against COVID-19. She emphasizes the need for timely alerts and empowering communities to protect vulnerable individuals.

Doe Kley, MPH, RN, T-CHEST, LTC-CIP, CIC, speaks to Infection Control Today about her presentation and other exceptional presentations at the Association for the Health Care Environment (AHE) Exchange Conference & Solution Center

The AHE Exchange Conference in Dallas focused on emerging pathogens and the role of environmental services. Doe Kley, MPH, RN, T-CHEST, LTC-CIP, CIC, discusses hers and other exceptional presentations with Infection Control Today.

Ambassador Deborah Birx, MD, discusses whether students should be required to wear masks to protect themselves and others and what the public should know about the newest COVID-19 variant, B.A.2.86.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.

Plague doctors' historical attire was an early form of PPE. While modern PPE has improved, the quest for better, more comfortable protection continues as we aim for a future where health care workers can provide care confidently.

Health care environmental professionals met in Dallas, Texas, from July 31 to August 2, 2023, at the AHE Exchange Conference & Solution Center. Infection Control Today® asked Rock Jensen, AHE advisory board chair and administrative director of support services for Yuma Regional Medical Center in Arizona, about AHE’s areas of emphasis for leadership in environmental services (EVS).

Besides its influenza pipeline, mRNA technology is helping this pharmaceutical company create a number of new vaccines for cancer, rare diseases, and infectious diseases.

Hepatitis C cases increased in 2021, while A and B decreased. The pandemic may have impacted the progress.

A recent survey aimed to understand Americans' concerns and knowledge about hospitalization. Infection Control Today speaks to 2 of the authors.

A recent conference highlights patient safety in health care and aims to reduce risks and harm to patients during medical care. It's a response to the growing complexity of health care systems and the resulting increase in patient harm.

All eye drops from Dr. Berne’s Whole Health Products are being recalled after FDA warning on August 24. There are 2 adverse reactions reported so far.

This guide aims to assist hospitals in identifying and managing sepsis at an earlier stage. ICT interviews 1 of the authors.

Eagle Pharmaceuticals randomized its first patient in the Phase 2 study of CAL02, a safe and promising anti-toxin drug that treats severe community-acquired bacterial pneumonia without contributing to antibiotic resistance.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending Aug 20, 2023.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, tuberculosis, and changes in leadership at the CDC and NIAID.

Connecting and networking with colleagues, finding the right resources, and joining key organizations can help you become a better infection preventionist.

Visible-light continuous environmental disinfection system reduces microbial contamination and surgical site infections, as noted in an AJIC study. Experts explain the study and the technology.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending July 30, 2023.

A new remote sexual health testing provider is available to US public health officials. It aims to reduce the increasing spread of sexually transmitted infections.

In this opinion article, the authors discuss their concerns about the recent HICPAC/CDC proposals on infectious diseases.

Neal Buchalter, MBA, president of Parker Laboratories, spoke with Infection Control Today® in an exclusive interview about the product, the companies involved, and how it came to the US market.

AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.